Expert Rev Neurother · 2019
Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHDConclusion: However, they may offer comparable or better tolerability. Additionally, agents acting on etiopathophysiological targets disrupted in specific subgroups of patients with ADHD will move forward the pharmacotherapy of ADHD from a 'one size fits all' to a 'precision medicine' approach.